BCL2L11 and endometrium adenocarcinoma: In human endometrial adenocarcinoma, miR-106a mimics co-transfected with wild-type BCL2L11 3′-UTR markedly inhibited the relative luciferase activities of RL95-2 and HEC-1B cells, suggesting that BCL2L11 is the direct target of miR-106a [28].